Panel recommends new, better shingles shot over old version


Make text smaller Make text larger



Photos





By MIKE STOBBE

A federal panel is recommending that older people vaccinated for shingles get a new, better shot approved in October.

The advisory panel said the vaccine made by GlaxoSmithKline works better than the first one made by Merck, which has been sold in the U.S. since 2006. Health officials say many as 20 million Americans should get a second round.

Shingles, a painful blistery condition, occurs when the chickenpox virus resurfaces later in life. Merck's vaccine is recommended for people 60 and older. But health officials say its effectiveness drops sharply after about five years.

The Advisory Committee on Immunization Practices said doctors should first opt for Glaxo's Shingrix, licensed last week, which uses a new ingredient to boost its effectiveness. It was recommended for people 50 and older.



Make text smaller Make text larger

Comments

Pool Rules



MUST READ NEWS

Local students help produce 'A Doll’s House' at ESU
MILFORD — The East Stroudsburg University Theatre Department will present the 1879 Henrik Ibsen play "A Doll’s...
Read more »
Image

Let's celebrate the 50th observance of Earth Day in the produce aisle
To the Editor:
April 22 marks the 50th observance of Earth Day. Each of us can celebrate by reducing our driving, use of electric energy, and consumption of animals.

Read more »
Image

Pike's Peek
Where around town have you seen this welcoming front stoop? If you think you know, fill out the form below.
Read more »
Image

Pike's Peek
It was only the most veteran Peek players who knew where to find last week's detail.
Pike County Commissioner Matt Osterberg writes that the clue may be found at "305...

Read more »
Image

VIDEOS



Subscribe to our mailing list

* indicates required
Community Newspapers


MOST READ

Entertainment
An aviary comes to the ARTery
  • Apr 18, 2018

MOST COMMENTED



Weather in Milford, PA